Subhajit Chatterjee

592 total citations
20 papers, 447 citations indexed

About

Subhajit Chatterjee is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Subhajit Chatterjee has authored 20 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Oncology and 4 papers in Immunology. Recurrent topics in Subhajit Chatterjee's work include Cell death mechanisms and regulation (6 papers), PARP inhibition in cancer therapy (5 papers) and DNA Repair Mechanisms (4 papers). Subhajit Chatterjee is often cited by papers focused on Cell death mechanisms and regulation (6 papers), PARP inhibition in cancer therapy (5 papers) and DNA Repair Mechanisms (4 papers). Subhajit Chatterjee collaborates with scholars based in India, United States and United Arab Emirates. Subhajit Chatterjee's co-authors include Chanakya Nath Kundu, Saptarshi Sinha, Chinmayee Sethy, Krushna Chandra Hembram, Rajalaxmi Pradhan, Mahitosh Mandal, Biswajit Das, Deepika Nayak, Rakesh K. Gupta and Birendra Kumar Bindhani and has published in prestigious journals such as PLoS ONE, Experimental Cell Research and European Journal of Pharmacology.

In The Last Decade

Subhajit Chatterjee

19 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Subhajit Chatterjee India 15 253 173 78 53 43 20 447
Saptarshi Sinha India 13 233 0.9× 194 1.1× 58 0.7× 34 0.6× 19 0.4× 23 410
Jiayi Lin China 15 348 1.4× 149 0.9× 103 1.3× 19 0.4× 25 0.6× 45 580
Igor Piotrowski Poland 13 191 0.8× 176 1.0× 70 0.9× 42 0.8× 81 1.9× 31 545
Kunyuan Guo China 13 202 0.8× 91 0.5× 118 1.5× 20 0.4× 43 1.0× 49 499
Jinbo Yuan China 16 401 1.6× 189 1.1× 48 0.6× 76 1.4× 19 0.4× 35 667
Fatemeh Karimi Dermani Iran 7 247 1.0× 291 1.7× 145 1.9× 36 0.7× 25 0.6× 8 587
Hardik Mody United States 12 240 0.9× 219 1.3× 54 0.7× 18 0.3× 14 0.3× 27 447
Xiaolong Li China 13 288 1.1× 99 0.6× 56 0.7× 31 0.6× 20 0.5× 48 492
Xingchen Ding China 11 208 0.8× 191 1.1× 111 1.4× 29 0.5× 22 0.5× 24 419

Countries citing papers authored by Subhajit Chatterjee

Since Specialization
Citations

This map shows the geographic impact of Subhajit Chatterjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Subhajit Chatterjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Subhajit Chatterjee more than expected).

Fields of papers citing papers by Subhajit Chatterjee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Subhajit Chatterjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Subhajit Chatterjee. The network helps show where Subhajit Chatterjee may publish in the future.

Co-authorship network of co-authors of Subhajit Chatterjee

This figure shows the co-authorship network connecting the top 25 collaborators of Subhajit Chatterjee. A scholar is included among the top collaborators of Subhajit Chatterjee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Subhajit Chatterjee. Subhajit Chatterjee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sinha, Saptarshi, Krushna Chandra Hembram, & Subhajit Chatterjee. (2024). Targeting signaling pathways in cancer stem cells: A potential approach for developing novel anti-cancer therapeutics. International review of cell and molecular biology. 157–209. 2 indexed citations
2.
Chatterjee, Subhajit, et al.. (2024). Regulation of lipid and serine metabolism by the oncogene c-Myc. International review of cell and molecular biology. 389. 236–256. 1 indexed citations
3.
Chatterjee, Subhajit & Gabriel J. Starrett. (2024). Microhomology‐mediated repair machinery and its relationship with HPV‐mediated oncogenesis. Journal of Medical Virology. 96(5). e29674–e29674. 4 indexed citations
4.
Das, Biswajit, et al.. (2023). Quinacrine inhibits cMET-mediated metastasis and angiogenesis in breast cancer stem cells. Journal of Cell Communication and Signaling. 17(4). 1371–1388. 7 indexed citations
5.
Starrett, Gabriel J., Jae W. Lee, Subhajit Chatterjee, & Jaroslaw Jedrych. (2023). Detection of extensive host–virus DNA hybrids in human polyomavirus 7-associated pruritic rash. British Journal of Dermatology. 188(5). 675–677.
6.
Chatterjee, Subhajit, et al.. (2023). Veliparib (ABT-888), a PARP inhibitor potentiates the cytotoxic activity of 5-fluorouracil by inhibiting MMR pathway through deregulation of MSH6 in colorectal cancer stem cells. Expert Opinion on Therapeutic Targets. 27(10). 999–1015. 14 indexed citations
7.
Sinha, Saptarshi, et al.. (2022). Olaparib enhances the Resveratrol-mediated apoptosis in breast cancer cells by inhibiting the homologous recombination repair pathway. Experimental Cell Research. 420(1). 113338–113338. 18 indexed citations
8.
Chatterjee, Subhajit, et al.. (2022). Combination of talazoparib and olaparib enhanced the curcumin-mediated apoptosis in oral cancer cells by PARP-1 trapping. Journal of Cancer Research and Clinical Oncology. 148(12). 3521–3535. 18 indexed citations
9.
Chatterjee, Subhajit, et al.. (2021). Olaparib enhances curcumin-mediated apoptosis in oral cancer cells by inducing PARP trapping through modulation of BER and chromatin assembly. DNA repair. 105. 103157–103157. 16 indexed citations
10.
Chatterjee, Subhajit, Saptarshi Sinha, & Chanakya Nath Kundu. (2021). Nectin cell adhesion molecule-4 (NECTIN-4): A potential target for cancer therapy. European Journal of Pharmacology. 911. 174516–174516. 61 indexed citations
11.
Pradhan, Rajalaxmi, Subhajit Chatterjee, Krushna Chandra Hembram, et al.. (2021). Nano formulated Resveratrol inhibits metastasis and angiogenesis by reducing inflammatory cytokines in oral cancer cells by targeting tumor associated macrophages. The Journal of Nutritional Biochemistry. 92. 108624–108624. 71 indexed citations
12.
Chatterjee, Subhajit, Saptarshi Sinha, Biswajit Das, et al.. (2021). NIR irradiation enhances the apoptotic potentiality of quinacrine-gold hybrid nanoparticles by modulation of HSP-70 in oral cancer stem cells. Nanomedicine Nanotechnology Biology and Medicine. 40. 102502–102502. 18 indexed citations
13.
14.
Chatterjee, Subhajit & Chanakya Nath Kundu. (2020). Nanoformulated quinacrine regulates NECTIN-4 domain specific functions in cervical cancer stem cells. European Journal of Pharmacology. 883. 173308–173308. 27 indexed citations
15.
Hembram, Krushna Chandra, Biswajit Das, Chinmayee Sethy, et al.. (2020). Quinacrine Based Gold Hybrid Nanoparticles Caused Apoptosis through Modulating Replication Fork in Oral Cancer Stem Cells. Molecular Pharmaceutics. 17(7). 2463–2472. 16 indexed citations
16.
Hembram, Krushna Chandra, Subhajit Chatterjee, Deepika Nayak, et al.. (2019). PARP inhibitor Olaparib Enhances the Apoptotic Potentiality of Curcumin by Increasing the DNA Damage in Oral Cancer Cells through Inhibition of BER Cascade. Pathology & Oncology Research. 26(4). 2091–2103. 24 indexed citations
17.
Sethy, Chinmayee, Deepika Nayak, Rajalaxmi Pradhan, et al.. (2019). Clinical significance of a pvrl 4 encoded gene Nectin-4 in metastasis and angiogenesis for tumor relapse. Journal of Cancer Research and Clinical Oncology. 146(1). 245–259. 42 indexed citations
18.
Hembram, Krushna Chandra, Subhajit Chatterjee, Chinmayee Sethy, et al.. (2019). Comparative and Mechanistic Study on the Anticancer Activity of Quinacrine-Based Silver and Gold Hybrid Nanoparticles in Head and Neck Cancer. Molecular Pharmaceutics. 16(7). 3011–3023. 19 indexed citations
19.
Chatterjee, Subhajit, et al.. (2018). Automatic outer and inner breast tissue segmentation using multi-parametric MRI images of breast tumor patients. PLoS ONE. 13(1). e0190348–e0190348. 26 indexed citations
20.
Mahajan, Umesh B., Sachin D. Shinde, Subhajit Chatterjee, et al.. (2018). A Chemosensitizer Drug: Disulfiram Prevents Doxorubicin-Induced Cardiac Dysfunction and Oxidative Stress in Rats. Cardiovascular Toxicology. 18(5). 459–470. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Saptarshi Sinha Breakdown of academic impact, for papers by Jiayi Lin Breakdown of academic impact, for papers by Igor Piotrowski Breakdown of academic impact, for papers by Kunyuan Guo Breakdown of academic impact, for papers by Jinbo Yuan Breakdown of academic impact, for papers by Fatemeh Karimi Dermani Breakdown of academic impact, for papers by Hardik Mody Breakdown of academic impact, for papers by Xiaolong Li Breakdown of academic impact, for papers by Xingchen Ding
Rankless by CCL
2026